Compare Moderna, Inc. (MRNA) vs NextEra Energy, Inc. (NEE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs NextEra Energy, Inc. — how do they compare? Moderna, Inc. trades at $63.61 (market cap $24.18B), while NextEra Energy, Inc. trades at $85.78 (market cap $178.85B). The key difference: NextEra Energy, Inc. is far larger — about 7.4× Moderna, Inc.'s market cap, and NextEra Energy, Inc. pays a 2.91% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | NEE | |
|---|---|---|
Market Cap | $24.18B | $178.85B |
Sector | Health | Utilities |
52-Week High | $81.80 | $97.88 |
52-Week Low | $22.36 | $69.77 |
Enterprise Value | $20.33B | $286.18B |
Dividend Yield | — | 2.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $63.70, up 6.5% recently, with a bullish technical signal and strong moving average support. Despite negative net income margins, the company beat Q2 2026 EPS estimates and secured FDA approval for its mRNA flu vaccine, mFLUSIVA, signaling diversification beyond COVID-19. Revenue has declined from pandemic peaks but is projected to stabilize around $2.2B in 2026.
The outlook is mixed: near-term catalysts from new vaccine approvals and pipeline progress offer upside, but persistent losses and high valuation multiples pose risks. Analyst consensus is cautious with a hold-heavy rating, reflecting uncertainty over profitability timelines amid ongoing R&D investments.
NextEra Energy (NEE) trades at $85.50, up 0.94% today, with a bearish technical signal but strong fundamentals including a 32.4% net income margin and recent earnings beats. The stock benefits from robust cash flow and a $100 billion data center partnership with Brookfield, positioning it as a key player in AI-driven power demand. Analyst consensus is bullish with a $100.40 price target, though technical indicators show resistance near $86.
Outlook is positive due to growth in electricity demand from AI data centers, supported by a 66.7% buy rating from analysts. Risks include high debt levels and volatile net cash flow. The stock offers a dividend yield of approximately 2.9%, with potential upside from execution on large-load projects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →
